Contributors |
|
xi | |
Preface |
|
xiii | |
|
|
1 | (46) |
|
|
|
3 | (6) |
|
|
|
|
Concept of Exercise Is Medicine |
|
|
4 | (1) |
|
Evidence-Based Guidelines |
|
|
4 | (2) |
|
|
6 | (1) |
|
Problem-Oriented Management |
|
|
7 | (1) |
|
|
8 | (1) |
|
|
8 | (1) |
|
|
8 | (1) |
|
|
8 | (1) |
|
Approach to Exercise and Disease Management |
|
|
9 | (12) |
|
|
|
|
Problem-Oriented Exercise Management |
|
|
9 | (3) |
|
Categories of Exercise Test Measures |
|
|
12 | (4) |
|
|
16 | (2) |
|
|
18 | (1) |
|
|
19 | (1) |
|
|
19 | (2) |
|
|
21 | (10) |
|
|
|
|
|
|
|
|
22 | (1) |
|
|
22 | (3) |
|
Exercise and Cardiovascular Diseases |
|
|
25 | (1) |
|
|
26 | (1) |
|
Current and Future Priorities |
|
|
26 | (1) |
|
Education for Exercise Professionals |
|
|
27 | (3) |
|
|
30 | (1) |
|
Managing Exercise in Persons With Multiple Chronic Conditions |
|
|
31 | (7) |
|
|
|
|
|
Overview of the Pathophysiology |
|
|
31 | (4) |
|
Effects on the Exercise Response |
|
|
35 | (1) |
|
Role of Exercise Training |
|
|
35 | (1) |
|
Recommendations for Exercise Testing |
|
|
36 | (1) |
|
Recommendations for Exercise Programming |
|
|
36 | (1) |
|
|
37 | (1) |
|
Physical Activity for Children and Adolescents |
|
|
38 | (9) |
|
|
|
Effects of Health Status and Physical Activity on Growth and Development |
|
|
39 | (1) |
|
Normal Responses to Physical Activity in Children and Adolescents |
|
|
39 | (2) |
|
Exercise Testing of Children and Adolescents |
|
|
41 | (1) |
|
General Physical Activity Concerns for Children With a Chronic Health Condition or Disability |
|
|
41 | (1) |
|
Selected Diseases and Disorders of Children and Youth |
|
|
42 | (2) |
|
|
44 | (3) |
|
PART II Cardiovascular Diseases |
|
|
47 | (80) |
|
|
|
|
49 | (9) |
|
|
Overview of the Pathophysiology |
|
|
49 | (1) |
|
Effects on the Exercise Response |
|
|
50 | (1) |
|
Effects of Exercise Training |
|
|
51 | (1) |
|
Management and Medications |
|
|
51 | (1) |
|
|
52 | (1) |
|
Recommendations for Exercise Testing |
|
|
53 | (1) |
|
Recommendations for Exercise Programming |
|
|
53 | (3) |
|
|
56 | (2) |
|
Revascularization: CABGS and PTCA or PCI |
|
|
58 | (8) |
|
|
Overview of the Pathophysiology |
|
|
58 | (2) |
|
Effects on the Exercise Response |
|
|
60 | (1) |
|
Effects of Exercise Training |
|
|
60 | (1) |
|
Management and Medications |
|
|
61 | (1) |
|
Recommendations for Exercise Testing |
|
|
61 | (1) |
|
Recommendations for Exercise Programming |
|
|
62 | (2) |
|
|
64 | (2) |
|
Angina and Silent Ischemia |
|
|
66 | (7) |
|
|
|
Overview of the Pathophysiology |
|
|
66 | (1) |
|
Effects on the Exercise Response |
|
|
67 | (1) |
|
Effects of Exercise Training |
|
|
68 | (1) |
|
Management and Medications |
|
|
68 | (1) |
|
Recommendations for Exercise Testing |
|
|
69 | (1) |
|
Recommendations for Exercise Programming |
|
|
70 | (2) |
|
|
72 | (1) |
|
|
73 | (6) |
|
|
|
Overview of the Pathophysiology |
|
|
73 | (1) |
|
Effects on the Exercise Response |
|
|
73 | (1) |
|
Effects of Exercise Training |
|
|
74 | (1) |
|
Management and Medications |
|
|
74 | (1) |
|
Recommendations for Exercise Testing |
|
|
74 | (2) |
|
Recommendations for Exercise Programming |
|
|
76 | (1) |
|
|
77 | (2) |
|
Pacemakers and Implantable Cardioverter Defibrillators |
|
|
79 | (6) |
|
|
|
Overview of the Pathophysiology |
|
|
79 | (1) |
|
Effects on the Exercise Response |
|
|
80 | (1) |
|
Effects of Exercise Training |
|
|
81 | (1) |
|
Management and Medications |
|
|
81 | (1) |
|
Recommendations for Exercise Testing |
|
|
81 | (1) |
|
Recommendations for Exercise Programming |
|
|
81 | (2) |
|
|
83 | (2) |
|
|
85 | (7) |
|
|
|
Overview of the Pathophysiology |
|
|
85 | (2) |
|
Effects on the Exercise Response |
|
|
87 | (1) |
|
Effects of Exercise Training |
|
|
88 | (1) |
|
Management and Medications |
|
|
88 | (1) |
|
|
88 | (1) |
|
Recommendations for Exercise Testing |
|
|
88 | (1) |
|
Recommendations for Exercise Programming |
|
|
89 | (1) |
|
|
90 | (1) |
|
|
91 | (1) |
|
|
92 | (7) |
|
|
|
Overview of the Pathophysiology |
|
|
92 | (1) |
|
Effects on the Exercise Response |
|
|
92 | (1) |
|
Effects of Exercise Training |
|
|
93 | (1) |
|
Management and Medications |
|
|
94 | (1) |
|
Recommendations for Exercise Testing |
|
|
94 | (2) |
|
Recommendations for Exercise Programming |
|
|
96 | (1) |
|
|
97 | (2) |
|
|
99 | (8) |
|
|
|
Overview of the Pathophysiology |
|
|
99 | (1) |
|
Effects on the Exercise Response |
|
|
100 | (1) |
|
Effects of Exercise Training |
|
|
100 | (1) |
|
Management and Medications |
|
|
100 | (1) |
|
Recommendations for Exercise Testing |
|
|
101 | (2) |
|
Recommendations for Exercise Programming |
|
|
103 | (2) |
|
|
105 | (2) |
|
|
107 | (7) |
|
|
Overview of the Pathophysiology |
|
|
107 | (1) |
|
Effects on the Exercise Response |
|
|
107 | (1) |
|
Effects of Exercise Training |
|
|
108 | (1) |
|
Management and Medications |
|
|
108 | (2) |
|
Recommendations for Exercise Testing |
|
|
110 | (1) |
|
Recommendations for Exercise Programming |
|
|
111 | (2) |
|
|
113 | (1) |
|
Peripheral Arterial Disease |
|
|
114 | (6) |
|
|
|
|
Overview of the Pathophysiology |
|
|
114 | (1) |
|
Effects on the Exercise Response |
|
|
115 | (1) |
|
Effects of Exercise Training |
|
|
115 | (1) |
|
Management and Medications |
|
|
115 | (1) |
|
Recommendations for Exercise Testing |
|
|
115 | (2) |
|
Recommendations for Exercise Programming |
|
|
117 | (1) |
|
|
118 | (2) |
|
|
120 | (7) |
|
|
Overview of the Pathophysiology |
|
|
120 | (1) |
|
Effects on the Exercise Response |
|
|
121 | (1) |
|
Effects of Exercise Training |
|
|
121 | (1) |
|
Management and Medications |
|
|
122 | (1) |
|
Recommendations for Exercise Testing |
|
|
122 | (1) |
|
Recommendations for Exercise Programming |
|
|
122 | (1) |
|
|
123 | (2) |
|
|
125 | (2) |
|
PART III Pulmonary Diseases |
|
|
127 | (29) |
|
|
Chronic Obstructive Pulmonary Disease |
|
|
129 | (7) |
|
|
Overview of the Pathophysiology |
|
|
129 | (1) |
|
Effects on the Exercise Response |
|
|
130 | (1) |
|
Effects of Exercise Training |
|
|
131 | (1) |
|
Management and Medications |
|
|
131 | (1) |
|
Recommendations for Exercise Testing |
|
|
132 | (1) |
|
Recommendations for Exercise Programming |
|
|
132 | (3) |
|
|
135 | (1) |
|
Chronic Restrictive Pulmonary Disease |
|
|
136 | (7) |
|
|
Overview of the Pathophysiology |
|
|
136 | (1) |
|
Effects on the Exercise Response |
|
|
137 | (1) |
|
Effects of Exercise Training |
|
|
138 | (1) |
|
Management and Medications |
|
|
138 | (1) |
|
Recommendations for Exercise Testing |
|
|
139 | (1) |
|
Recommendations for Exercise Programming |
|
|
139 | (3) |
|
|
142 | (1) |
|
|
143 | (7) |
|
|
|
Overview of the Pathophysiology |
|
|
143 | (1) |
|
Effects on the Exercise Response |
|
|
143 | (1) |
|
Effects of Exercise Training |
|
|
144 | (1) |
|
Management and Medications |
|
|
144 | (1) |
|
Recommendations for Exercise Testing |
|
|
145 | (1) |
|
Recommendations for Exercise Programming |
|
|
146 | (3) |
|
|
149 | (1) |
|
|
150 | (6) |
|
|
Overview of the Pathophysiology |
|
|
150 | (1) |
|
Effects on the Exercise Response |
|
|
150 | (1) |
|
Effects of Exercise Training |
|
|
151 | (1) |
|
Management and Medications |
|
|
151 | (1) |
|
Recommendations for Exercise Testing |
|
|
152 | (1) |
|
Recommendations for Exercise Programming |
|
|
153 | (1) |
|
|
153 | (2) |
|
|
155 | (1) |
|
Lung and Heart-Lung Transplantation |
|
|
156 | (1) |
|
|
|
Overview of the Pathophysiology |
|
|
156 | (1) |
|
Effects on the Exercise Response |
|
|
157 | (1) |
|
Effects of Exercise Training |
|
|
158 | (1) |
|
Management and Medications |
|
|
158 | (1) |
|
Recommendations for Exercise Testing |
|
|
159 | (2) |
|
Recommendations for Exercise Programming |
|
|
161 | (2) |
|
|
163 | (1) |
|
|
163 | |
|
PART IV Metabolic Diseases |
|
|
156 | (9) |
|
|
Overview of the Pathophysiology |
|
|
156 | (1) |
|
Effects on the Exercise Response |
|
|
157 | (1) |
|
Effects of Exercise Training |
|
|
158 | (1) |
|
Management and Medications |
|
|
158 | (1) |
|
Recommendations for Exercise Testing |
|
|
159 | (2) |
|
Recommendations for Exercise Programming |
|
|
161 | (2) |
|
|
163 | (1) |
|
|
163 | (2) |
|
PART IV Metabolic Diseases |
|
|
165 | (44) |
|
|
|
|
167 | (8) |
|
|
|
|
Overview of the Pathophysiology |
|
|
167 | (1) |
|
Effects on the Exercise Response |
|
|
168 | (1) |
|
Effects of Exercise Training |
|
|
168 | (1) |
|
Management and Medications |
|
|
169 | (2) |
|
Recommendations for Exercise Testing |
|
|
171 | (1) |
|
Recommendations for Exercise Programming |
|
|
171 | (2) |
|
|
173 | (2) |
|
End-Stage Metabolic Disease: Chronic Kidney Disease and Liver Failure |
|
|
175 | (7) |
|
|
|
Overview of the Pathophysiology |
|
|
175 | (1) |
|
Effects on the Exercise Response |
|
|
176 | (1) |
|
Effects of Exercise Training |
|
|
176 | (1) |
|
Management and Medications |
|
|
177 | (1) |
|
Recommendations for Exercise Testing |
|
|
178 | (1) |
|
Recommendations for Exercise Programming |
|
|
179 | (1) |
|
|
180 | (2) |
|
|
182 | (10) |
|
|
|
Overview of the Pathophysiology |
|
|
182 | (2) |
|
Effects on the Exercise Response |
|
|
184 | (1) |
|
Effects of Exercise Training |
|
|
184 | (1) |
|
Management and Medications |
|
|
184 | (3) |
|
Recommendations for Exercise Testing |
|
|
187 | (1) |
|
Recommendations for Exercise Programming |
|
|
188 | (2) |
|
|
190 | (2) |
|
|
192 | (9) |
|
|
|
Overview of the Pathophysiology |
|
|
192 | (2) |
|
Effects on the Exercise Response |
|
|
194 | (1) |
|
Effects of Exercise Training |
|
|
195 | (1) |
|
Management and Medications |
|
|
195 | (1) |
|
Recommendations for Exercise Testing |
|
|
196 | (1) |
|
Recommendations for Exercise Programming |
|
|
196 | (1) |
|
|
197 | (2) |
|
|
199 | (2) |
|
|
201 | (8) |
|
|
|
|
Overview of the Pathophysiology |
|
|
201 | (1) |
|
Effects on the Exercise Response |
|
|
201 | (2) |
|
Effects of Exercise Training |
|
|
203 | (1) |
|
Management and Medications |
|
|
203 | (1) |
|
Recommendations for Exercise Testing |
|
|
204 | (2) |
|
Recommendations for Exercise Programming |
|
|
206 | (1) |
|
|
207 | (2) |
|
PART V Immunolagical and Hematological Disorders |
|
|
209 | (48) |
|
|
|
|
211 | (8) |
|
|
Overview of the Pathophysiology |
|
|
211 | (1) |
|
Effects on the Exercise Response |
|
|
211 | (1) |
|
Effects of Exercise Training |
|
|
212 | (1) |
|
Management and Medications |
|
|
213 | (1) |
|
Recommendations for Exercise Testing |
|
|
214 | (1) |
|
Recommendations for Exercise Programming |
|
|
214 | (3) |
|
|
217 | (2) |
|
Acquired Immune Deficiency Syndrome [ AIDS] |
|
|
219 | (7) |
|
|
|
|
Overview of the Pathophysiology |
|
|
219 | (1) |
|
Effects on the Exercise Response |
|
|
220 | (1) |
|
Effects of Exercise Training |
|
|
221 | (1) |
|
Management and Medications |
|
|
221 | (1) |
|
Recommendations for Exercise Testing |
|
|
222 | (1) |
|
Recommendations for Exercise Programming |
|
|
223 | (1) |
|
|
224 | (1) |
|
|
224 | (2) |
|
Abdominal Organ Transplant [ Kidney, Liver, Pancreas] |
|
|
226 | (7) |
|
|
|
Overview of the Pathophysiology |
|
|
226 | (1) |
|
Effects on the Exercise Response |
|
|
227 | (1) |
|
Effects of Exercise Training |
|
|
227 | (1) |
|
Management and Medications |
|
|
227 | (1) |
|
Recommendations for Exercise Testing |
|
|
228 | (1) |
|
Recommendations for Exercise Programming |
|
|
228 | (3) |
|
|
231 | (2) |
|
|
233 | (6) |
|
|
Overview of the Pathophysiology |
|
|
233 | (1) |
|
Effects on the Exercise Response |
|
|
234 | (1) |
|
Effects of Exercise Training |
|
|
234 | (1) |
|
Management and Medications |
|
|
234 | (1) |
|
Recommendations for Exercise Testing |
|
|
235 | (1) |
|
Recommendations for Exercise Programming |
|
|
235 | (2) |
|
|
237 | (1) |
|
|
237 | (2) |
|
|
239 | (7) |
|
|
|
Overview of the Pathophysiology |
|
|
239 | (1) |
|
Effects on the Exercise Response |
|
|
239 | (1) |
|
Effects of Exercise Training |
|
|
240 | (1) |
|
Management and Medications |
|
|
240 | (1) |
|
Recommendations for Exercise Testing |
|
|
241 | (1) |
|
Recommendations for Exercise Programming |
|
|
242 | (2) |
|
|
244 | (1) |
|
|
245 | (1) |
|
|
246 | (11) |
|
|
Overview of the Pathophysiology |
|
|
246 | (1) |
|
Effects on the Exercise Response |
|
|
247 | (1) |
|
Effects of Exercise Training |
|
|
247 | (1) |
|
Management and Medications |
|
|
247 | (1) |
|
Recommendations for Exercise Testing |
|
|
248 | (1) |
|
Recommendations for Exercise Programming |
|
|
248 | (1) |
|
|
249 | (8) |
|
Bleeding and Clotting Disorders |
|
|
257 | (1) |
|
|
|
Overview of the Pathophysiology |
|
|
250 | (1) |
|
Effects on the Exercise Response |
|
|
251 | (1) |
|
Effects of Exercise Training |
|
|
252 | (1) |
|
Management and Medications |
|
|
253 | (1) |
|
Recommendations for Exercise Testing |
|
|
254 | (1) |
|
Recommendations for Exercise Programming |
|
|
254 | (1) |
|
|
255 | (1) |
|
|
256 | (1) |
|
PART VI Orthopedic Diseases and Disabilities |
|
|
257 | (28) |
|
|
|
259 | (7) |
|
|
|
Overview of the Pathophysiology |
|
|
259 | (1) |
|
Effects on the Exercise Response |
|
|
260 | (1) |
|
Effects of Exercise Training |
|
|
260 | (1) |
|
Management and Medications |
|
|
261 | (1) |
|
Recommendations for Exercise Testing |
|
|
261 | (1) |
|
Recommendations for Exercise Programming |
|
|
262 | (3) |
|
|
265 | (1) |
|
|
266 | (4) |
|
|
|
Overview of the Pathophysiology |
|
|
266 | (1) |
|
Effects on the Exercise Response |
|
|
266 | (1) |
|
Effects of Exercise Training |
|
|
267 | (1) |
|
Management and Medications |
|
|
267 | (1) |
|
Recommendations for Exercise Testing |
|
|
267 | (1) |
|
Recommendations for Exercise Programming |
|
|
267 | (2) |
|
|
269 | (1) |
|
|
270 | (10) |
|
|
Che-Hsiang Elizabeth Wang |
|
|
|
Overview of the Pathophysiology |
|
|
270 | (2) |
|
Effects on the Exercise Response |
|
|
272 | (1) |
|
Effects of Exercise Training |
|
|
272 | (1) |
|
Management and Medications |
|
|
272 | (1) |
|
Recommendations for Exercise Testing |
|
|
273 | (2) |
|
Recommendations for Exercise Programming |
|
|
275 | (1) |
|
|
276 | (1) |
|
|
277 | (3) |
|
|
280 | (5) |
|
|
|
Overview of the Pathophysiology |
|
|
280 | (1) |
|
Effects on the Exercise Response |
|
|
281 | (1) |
|
Effects on Exercise Training |
|
|
281 | (1) |
|
Management and Medications |
|
|
281 | (1) |
|
Recommendations for Exercise Testing |
|
|
282 | (1) |
|
Recommendations for Exercise Programming |
|
|
283 | (1) |
|
|
284 | (1) |
|
PART VII Neuromuscular Disorders |
|
|
285 | (72) |
|
|
|
287 | (11) |
|
|
|
Overview of the Pathophysiology |
|
|
287 | (1) |
|
Effects on the Exercise Response |
|
|
288 | (1) |
|
Effects of Exercise Training |
|
|
289 | (1) |
|
Management and Medications |
|
|
289 | (1) |
|
Recommendations for Exercise Testing |
|
|
290 | (2) |
|
Recommendations for Exercise Programming |
|
|
292 | (3) |
|
|
295 | (3) |
|
Spinal Cord Disabilities: Paraplegia and Tetraplegia |
|
|
298 | (8) |
|
|
Overview of the Pathophysiology |
|
|
298 | (1) |
|
Effects on the Exercise Response |
|
|
299 | (1) |
|
Effects of Exercise Training |
|
|
299 | (1) |
|
Management and Medications |
|
|
299 | (1) |
|
Recommendations for Exercise Testing |
|
|
300 | (1) |
|
Recommendations for Exercise Programming |
|
|
301 | (1) |
|
|
302 | (2) |
|
|
304 | (2) |
|
|
306 | (8) |
|
|
Overview of the Pathophysiology |
|
|
306 | (1) |
|
Effects on the Exercise Response |
|
|
307 | (1) |
|
Effects of Exercise Training |
|
|
307 | (1) |
|
Management and Medications |
|
|
308 | (1) |
|
Recommendations for Exercise Testing |
|
|
308 | (2) |
|
Recommendations for Exercise Programming |
|
|
310 | (1) |
|
|
311 | (1) |
|
|
312 | (2) |
|
|
314 | (7) |
|
|
Overview of the Pathophysiology |
|
|
314 | (2) |
|
Effects on the Exercise Response |
|
|
316 | (1) |
|
Effects of Exercise Training |
|
|
316 | (1) |
|
Management and Medications |
|
|
316 | (2) |
|
Recommendations for Exercise Testing |
|
|
318 | (1) |
|
Recommendations for Exercise Programming |
|
|
318 | (2) |
|
|
320 | (1) |
|
|
321 | (6) |
|
|
|
Overview of the Pathophysiology |
|
|
321 | (1) |
|
Effects on the Exercise Response |
|
|
321 | (1) |
|
Effects of Exercise Training |
|
|
321 | (1) |
|
Management and Medications |
|
|
322 | (1) |
|
Recommendations for Exercise Testing |
|
|
322 | (1) |
|
Recommendations for Exercise Programming |
|
|
323 | (1) |
|
|
324 | (1) |
|
|
325 | (2) |
|
Polio and Post-Polio Syndrome |
|
|
327 | (9) |
|
|
Overview of the Pathophysiology |
|
|
327 | (1) |
|
Effects on the Exercise Response |
|
|
328 | (1) |
|
Effects of Exercise Training |
|
|
328 | (1) |
|
Management and Medications |
|
|
328 | (1) |
|
Recommendations for Exercise Testing |
|
|
329 | (2) |
|
Recommendations for Exercise Programming |
|
|
331 | (2) |
|
|
333 | (1) |
|
|
333 | (3) |
|
Amyotrophic Lateral Sclerosis |
|
|
336 | (7) |
|
|
|
Overview of the Pathophysiology |
|
|
336 | (1) |
|
Effects on the Exercise Response |
|
|
337 | (1) |
|
Effects of Exercise Training |
|
|
337 | (1) |
|
Management and Medications |
|
|
338 | (1) |
|
Recommendations for Exercise Testing |
|
|
338 | (1) |
|
Recommendations for Exercise Programming |
|
|
338 | (2) |
|
|
340 | (2) |
|
|
342 | (1) |
|
|
343 | (7) |
|
|
Overview of the Pathophysiology |
|
|
343 | (1) |
|
Effects on the Exercise Response |
|
|
344 | (1) |
|
Effects of Exercise Training |
|
|
344 | (1) |
|
Management and Medications |
|
|
345 | (1) |
|
Recommendations for Exercise Testing |
|
|
345 | (2) |
|
Recommendations for Exercise Programming |
|
|
347 | (1) |
|
|
348 | (2) |
|
|
350 | (7) |
|
|
|
|
Overview of the Pathophysiology |
|
|
350 | (1) |
|
Effects on the Exercise Response |
|
|
351 | (1) |
|
Effects of Exercise Training |
|
|
351 | (1) |
|
Management and Medications |
|
|
352 | (1) |
|
Recommendations for Exercise Testing |
|
|
353 | (1) |
|
Recommendations for Exercise Programming |
|
|
353 | (2) |
|
|
355 | (2) |
|
PART VIII Cognitive, Psychological, and Sensory Disorders |
|
|
357 | (40) |
|
Lorraine E. Colson Bloomquist |
|
|
Intellectual Disabilities |
|
|
359 | (9) |
|
|
Overview of the Pathophysiology |
|
|
359 | (2) |
|
Effects on the Exercise Response |
|
|
361 | (1) |
|
Effects of Exercise Training |
|
|
361 | (1) |
|
Management and Medications |
|
|
362 | (1) |
|
Recommendations for Exercise Testing |
|
|
362 | (3) |
|
Recommendations for Exercise Programming |
|
|
365 | (1) |
|
|
366 | (1) |
|
|
367 | (1) |
|
|
368 | (7) |
|
|
|
Overview of the Pathophysiology |
|
|
368 | (2) |
|
Management and Medications |
|
|
370 | (1) |
|
Effects on the Exercise Response and Exercise Training |
|
|
370 | (1) |
|
Recommendations for Exercise Testing |
|
|
370 | (1) |
|
Recommendations for Exercise Programming |
|
|
371 | (2) |
|
|
373 | (1) |
|
|
374 | (1) |
|
|
375 | (1) |
|
|
|
Overview of the Pathophysiology |
|
|
375 | (1) |
|
Effects on the Exercise Response |
|
|
375 | (1) |
|
Effects of Exercise Training |
|
|
376 | (1) |
|
Management and Medications |
|
|
376 | (1) |
|
Recommendations for Exercise Testing |
|
|
376 | (1) |
|
Recommendations for Exercise Programming |
|
|
377 | (1) |
|
|
378 | |
|
Stress and Anxiety Disorders |
|
|
375 | (10) |
|
|
|
|
Overview of the Pathophysiology |
|
|
379 | (1) |
|
Effects on the Exercise Response |
|
|
380 | (1) |
|
Effects of Exercise Training |
|
|
380 | (1) |
|
Management and Medications |
|
|
381 | (1) |
|
Recommendations for Exercise Testing |
|
|
382 | (1) |
|
Recommendations for Exercise Programming |
|
|
382 | (1) |
|
|
383 | (1) |
|
|
383 | (2) |
|
|
385 | (7) |
|
|
|
Overview of the Pathophysiology |
|
|
385 | (2) |
|
Effects on the Exercise Response |
|
|
387 | (1) |
|
Effects of Exercise Training |
|
|
387 | (1) |
|
Recommendations for Exercise Testing |
|
|
388 | (1) |
|
Recommendations for Exercise Programming |
|
|
388 | (1) |
|
|
388 | (2) |
|
|
390 | (2) |
|
|
392 | (5) |
|
|
Overview of the Pathophysiology |
|
|
392 | (1) |
|
Effects on the Exercise Response |
|
|
392 | (1) |
|
Effects of Exercise Training |
|
|
393 | (1) |
|
Management and Medications |
|
|
393 | (1) |
|
Recommendations for Exercise Testing |
|
|
393 | (1) |
|
Recommendations for Exercise Programming |
|
|
394 | (1) |
|
|
395 | (2) |
Appendix |
|
397 | (10) |
Suggested Readings |
|
407 | (22) |
Index |
|
429 | (11) |
About the ACSM |
|
440 | |